2,2-Difluoro-2-(3-methoxyphenyl)ethan-1-amine (hydrochloride), 1g

tert-Butyl (3-cyano-7-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[b]thiophen-2-yl)carbamate, 95%+, 25g

Cediranib, 99.0%, 100mg

methyl 3H-imidazo[4,5-b]pyridine-5-carboxylate, 100mg

4-Amino-3-methyl-2-(trifluoromethyl)benzonitrile, 98%, 1g

1-(NAPHTHALEN-1-YL)PROPAN-1-AMINE, 95.0%, 250mg

5-Bromo-6-hydroxy-2-methylpyrimidin-4(1H)-one, 95.0%, 10g

1-(3,4-dichlorobenzoyl)piperazine, 95.0%, 2g

(5-Methyl-4-phenyl-thiazol-2-yl)-hydrazine, 97%, 1g

Analytical and precision scale Entris® II series Models with internal adjustment, factory calibrated, 0.001 g, 620 g, BCE623i-1CEU (W)

4-Chloromethyl-2-methylthiazole hydrochloride, 95.0%, 1g

3-Bromo-2,6-difluorobenzaldehyde, 98.0%, 10g

N-(3-(DIFLUOROMETHYL)PHENYL)-N,O-DIMETHYLHYDROXYLAMINE, 95.0%, 1g